September 22, 2026
IRC Partners Research

What Revenue-Quality Issues Can Cause Growth Equity Investors To Pass On a Series B Deal?

In This Article
Revenue-quality issues graphic beside Series B growth charts and financial reports in a bright office.
September 22, 2026

What Revenue-Quality Issues Can Cause Growth Equity Investors To Pass On a Series B Deal?

Growth equity investors may pass on a Series B deal when revenue is concentrated, ARR includes non-recurring fees, gross margins lag SaaS benchmarks, or ACV is declining. Before outreach, founders should rebuild revenue metrics from contracts and examine concentration, margins, and ACV cohorts over time.

Revenue quality is the first filter growth equity investors apply at Series B. Before a lead investor models your valuation, evaluates your growth rate, or assesses your team, they run a revenue quality screen. Four specific problems end deals at this stage: customer concentration risk, non-recurring revenue inflating ARR, gross margins below institutional thresholds, and contracting average contract value trends. Each one signals a different kind of structural fragility. Together, they tell an investor that the revenue number on your cover slide does not mean what it appears to mean.

According to ICONIQ Growth's published benchmarking data, net dollar retention for institutional-grade B2B software companies has stabilized in the 110% to 120% range as of 2025, with early-stage companies showing the strongest retention performance in the dataset. Companies that fall below those thresholds at the time of raise face a materially harder process. The benchmark exists because investors use it as a proxy for revenue quality before they open a financial model.

The Capital Raise Pre-Flight is IRC Partners' fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership.

Understanding how growth equity investors evaluate a Series B company gives founders the full picture of the evaluation framework. Revenue quality is the gate that determines whether the rest of that evaluation even begins.

The four revenue quality red flags covered in this article:

  • Customer concentration that puts more than 10% to 20% of ARR in a single account
  • Non-recurring revenue booked inside ARR that distorts retention and growth metrics
  • Gross margins below the 70% to 75% threshold that institutional SaaS investors expect
  • Contracting ACV trends that signal pricing pressure, product commoditization, or a customer mix problem

Red Flag 1: Customer Concentration Above the 20% Threshold

Customer concentration is one of the fastest deal-killers at Series B because it converts ARR from a durable asset into a single-point-of-failure risk. Growth equity investors underwrite SaaS businesses on the assumption that revenue is repeatable and distributed. A single customer representing 20% or more of ARR breaks that assumption.

Growth equity investors treat customer concentration as a primary diligence flag at the Series B stage. The standard institutional threshold is 20% of ARR from a single customer, which triggers required explanation and mitigation before a round can be priced. At 30% or above, the issue moves from a flag to a frequent deal-stopper, based on the diligence standards documented across Bessemer Venture Partners' State of the Cloud research and the broader growth equity market.

Why Investors Price It as Existential Risk

The concern is straightforward. If that customer churns, renews at a lower value, or renegotiates terms, the company's reported ARR drops materially. A company reporting $15M ARR with one customer at $3.5M is reporting a number that is one renewal conversation away from a 23% reduction. Investors writing growth equity checks at the Series B stage do not take that risk on faith.

Concentration Level Investor Response
Below 10% per customer Acceptable; standard for institutional SaaS
10% to 20% per customer Flagged; requires explanation and churn history
Above 20% per customer Structural risk; often requires remediation before raise
Above 30% per customer Frequent deal-stopper at growth equity stage

How to Fix It Before Going to Market

Reducing concentration takes time, which is why founders need to identify this problem 12 to 18 months before a planned raise. The fix involves two parallel tracks: accelerating new customer acquisition in the $50K to $150K ACV range to dilute the concentration percentage, and securing multi-year contract extensions with the concentrated customer to reduce churn risk during the raise window. Investors will still flag the concentration, but a signed three-year renewal with a concentrated customer converts an existential risk into a manageable one.

Red Flag 2: Non-Recurring Revenue Inflating ARR

ARR is supposed to measure the annualized value of recurring, contracted revenue. When professional services fees, implementation charges, one-time setup fees, or variable usage revenue get included in the ARR figure, the number becomes unreliable as a predictor of future revenue. Growth equity investors build their valuation models on ARR. If the ARR is contaminated, the model is wrong.

Growth equity investors who rebuild ARR from contracts during diligence consistently strip professional services, one-time fees, and non-contracted usage revenue from the reported figure. Companies whose investor-calculated ARR differs materially from their reported ARR face longer diligence timelines and credibility questions across the rest of the data room.

What Counts as Non-Recurring Revenue

The categories investors strip out when they rebuild ARR from scratch:

  • Professional services and implementation fees. One-time charges to onboard a customer. These do not recur in year two.
  • Training and consulting revenue. Billed separately from the SaaS subscription. Margin profile is different; recurrence is uncertain.
  • One-time setup or customization fees. Common in enterprise deals. Investors exclude them from ARR and from the ARR growth rate calculation.
  • Variable usage revenue above contracted minimums. If a customer has a $100K base contract but billed $140K due to usage overages, only the $100K belongs in ARR.
  • Pilot or trial revenue. Revenue from pilots that have not converted to full contracts is sometimes booked as ARR. Investors will remove it.

What the Contamination Does to Your Metrics

The damage from non-recurring revenue in ARR extends beyond the top-line number. It inflates the ARR growth rate, understates churn (because non-recurring revenue that does not repeat looks like a renewal that did not happen), and distorts net revenue retention. A company with $18M in reported ARR that includes $2.5M in professional services is presenting a $15.5M ARR business with a services revenue line that investors will value at a much lower multiple.

The fix: Rebuild your ARR schedule from contracts before going to market. Separate subscription ARR, professional services revenue, and variable usage into distinct line items. Present the ARR number that matches what a growth equity investor will calculate when they do the same exercise. Arriving at the same number they would arrive at builds credibility. Arriving at a different number raises questions about everything else.

Red Flag 3: Gross Margins Below the 70% Institutional Threshold

Gross margin is the metric growth equity investors use to evaluate whether a SaaS business is structurally capable of generating the returns that justify a growth equity check. A company growing at 80% year-over-year with 55% gross margins is a fundamentally different investment than the same company with 78% gross margins. The valuation multiple, the capital efficiency story, and the path to profitability all change. Founders who want to understand how gross margin feeds directly into the valuation model should review how startup valuation works at the growth stage before going to market.

Why Margin Matters More Than Growth at This Stage

At Series A, investors are primarily funding growth. At Series B, they are funding a business model. The distinction matters because a business with low gross margins requires more capital to reach the same profitability milestone as a high-margin business. Growth equity investors model exit multiples on ARR, but they also model the capital required to get there. A company with 58% gross margins needs more of that capital to reach breakeven, which compresses the return on the growth equity check.

Gross Margin Range Signal to Investors
Above 80% Strong; top-quartile SaaS; supports premium multiples
70% to 80% Institutional standard; acceptable for most growth equity
60% to 70% Below benchmark; requires explanation; valuation pressure
Below 60% Significant concern; often indicates services-heavy or infrastructure-heavy model

Common Causes of Below-Threshold Margins

Several structural issues drive gross margins below 70% in B2B SaaS companies at the $10M to $30M ARR stage:

  • Hosting and infrastructure costs that have not been optimized. Early-stage companies often over-provision cloud infrastructure. At Series B scale, investors expect to see evidence of unit-level cost management.
  • Professional services included in cost of revenue. If the company is delivering significant implementation or customization work to close enterprise deals, those costs sit in COGS and compress gross margin.
  • Third-party data or licensing costs. Some SaaS products are built on top of data or software licenses that carry meaningful per-customer costs. These are legitimate but need to be explained and modeled.
  • Customer success headcount in COGS. How a company classifies customer success costs affects reported gross margin. Investors will reclassify to their preferred methodology and compare the result to benchmarks.

What to Do Before the Raise

Founders with gross margins below 70% have two options. The first is structural improvement: audit hosting costs, renegotiate vendor contracts, and reduce the services component of COGS before going to market. The second is transparent framing: present a gross margin bridge that shows the current margin, the drivers of the gap, and a credible path to 70%+ within 12 to 18 months post-raise. Investors can work with a margin improvement story. They struggle with a margin problem that has no explanation.

Red Flag 4: Contracting ACV Trends

Average contract value trends are a leading indicator of pricing power, product positioning, and customer mix trajectory. When ACV is declining over time, it tells a growth equity investor one of three things: the company is moving downmarket, customers are negotiating harder at renewal, or the product is losing differentiation against alternatives. All three interpretations raise the same concern: the revenue being generated today is worth less per customer than the revenue generated 18 months ago.

KeyBanc Capital Markets' SaaS survey tracks median ACV across more than 100 private SaaS companies annually. Their 2024 survey data shows a median ACV of $62,000 across the private B2B SaaS market, up from $56,000 in 2023 and $54,000 in 2022, reflecting an upmarket shift as companies pursue larger customers. A declining ACV trend in that range signals that the company is closing more deals at lower prices, which means more customers are needed to maintain the same ARR growth rate.

What a Declining ACV Trend Signals in Diligence

Growth equity investors look at ACV trend over six to eight quarters. The current number alone tells them nothing about direction. A company with a $40K median ACV today that sat at $52K two years ago is, as an example, a different business than one that has held $40K consistently. The declining trend raises questions that the current ACV alone does not:

  • Is the sales team discounting to hit quota? Heavy discounting compresses ACV without reducing deal count, making the revenue appear healthy until renewals come in at the discounted rate.
  • Has the ICP shifted downmarket? If the company started selling to mid-market and has drifted toward SMB, the ACV decline reflects a customer mix change that will compound over time.
  • Is the product losing competitive differentiation? Buyers who have more alternatives negotiate harder. A declining ACV in a market with new entrants is a product signal that runs deeper than the sales team.
  • Are multi-year deals disappearing? A shift from multi-year to annual contracts reduces ACV mechanically. Investors will ask why customers are choosing shorter commitments.

{{main-cta}}

How to Address It Before the Raise

The correction for contracting ACV depends on the cause. If the issue is discounting, the fix is a pricing discipline audit and a cohort analysis that shows renewal rates and expansion revenue by original deal price. If the issue is customer mix, the fix is a segmentation analysis that separates SMB, mid-market, and enterprise ACV trends and shows the company's intentional focus on the higher-value segment. If the issue is product differentiation, the fix requires product investment before the raise, which is why identifying this problem early matters.

What investors want to see instead of a declining ACV trend:

  • Stable or rising ACV over six to eight quarters
  • Expansion revenue from existing customers that lifts effective ACV above the initial contract value
  • A new business ACV that equals or exceeds the renewal ACV, indicating pricing power at acquisition

Founders preparing for a Series B should pull their ACV cohort data and trend it before any investor conversation. If the math is messy, common mistakes companies make in capital raising often show up first in the revenue story, not the pitch deck.

What to Do Before Investors Run This Screen on You

The four issues covered here, concentration risk, ARR contamination, weak gross margins, and contracting ACV, each have a fix. The problem is that the fix requires time. Founders who identify these issues six to twelve months before a planned raise have room to correct them. Founders who find them during diligence do not.

A pre-raise revenue quality audit covers four steps:

  1. Pull a customer-by-customer ARR breakdown and calculate concentration percentages for the top five accounts
  2. Rebuild ARR from signed contracts, stripping professional services, one-time fees, and variable usage above contracted minimums
  3. Calculate gross margin using the methodology institutional investors apply, separating hosting, third-party costs, and customer success classification
  4. Trend ACV by cohort over the last six to eight quarters and identify whether the movement is driven by discounting, customer mix, or contract term shifts

Founders who complete this audit before going to market arrive at investor conversations with the same numbers investors will calculate. That alignment builds credibility and compresses diligence timelines.

Frequently Asked Questions

What gross margin percentage do growth equity investors require for a Series B SaaS company?

The institutional benchmark, according to OpenView Partners' SaaS benchmarks report, is 70% to 80% gross margin for B2B SaaS companies at the growth equity stage. Top-quartile companies operate above 80%. Companies below 70% face valuation pressure and additional diligence questions about cost structure, services mix, and the path to margin improvement. A gross margin below 60% is a structural concern that most growth equity investors will require a detailed explanation for before proceeding.

How do investors define ARR differently from how founders report it?

When growth equity investors rebuild ARR from contracts during diligence, they include only contracted, recurring subscription revenue. Professional services fees, implementation charges, one-time setup costs, and variable usage revenue above contracted minimums are excluded. The resulting number is often materially lower than what founders presented on the cover slide. That gap creates credibility pressure across every other metric in the data room, because investors begin questioning what else was measured inconsistently.

At what customer concentration level does a Series B deal become difficult to close?

The standard institutional threshold is 20% of ARR from a single customer. At that level, growth equity investors require explicit explanation and a mitigation plan before a round can be priced. At 30% or above, the issue frequently becomes a deal-stopper. Growth equity investors underwrite SaaS revenue as distributed and repeatable. A single customer at 25% of ARR represents a churn event that could reduce reported ARR by a quarter overnight.

What does a declining ACV trend signal to a Series B investor?

A declining average contract value trend over six to eight quarters signals one of three things to a growth equity investor: the sales team is discounting to hit quota, the company has drifted downmarket toward lower-value customers, or the product is losing competitive differentiation and buyers are negotiating harder at renewal. All three interpretations raise concerns about pricing power and the durability of future revenue. KeyBanc Capital Markets' 2024 SaaS survey data shows the private B2B SaaS market median ACV at $62,000, up from $54,000 in 2022, with the trend driven by companies moving upmarket toward larger customers.

How far in advance should a founder audit revenue quality before a Series B?

Twelve to eighteen months before planned outreach. That window allows time to identify concentration issues and execute new customer acquisition campaigns to dilute them, rebuild the ARR schedule from contracts and correct any non-recurring items, address gross margin gaps through infrastructure optimization or vendor renegotiation, and prepare a credible ACV cohort analysis. Founders who begin this process after investor conversations have started are managing the problem under diligence pressure, which almost always produces worse outcomes.

Does professional services revenue hurt a Series B valuation even if it is growing?

When professional services revenue grows inside ARR, investors strip it out and apply a lower multiple to it. Services revenue carries a different margin profile and lower predictability than subscription ARR. A material services component also tells investors the product depends on heavy human effort to deploy, which is a scalability concern at the $10M to $30M ARR stage.

What is the difference between gross revenue retention and net revenue retention at Series B?

Gross revenue retention measures how much of last year's ARR was retained in the current year, excluding any expansion revenue. It captures pure churn and downgrades. Net revenue retention includes expansion revenue from upsells and cross-sells. ICONIQ Growth's published benchmarking data shows net dollar retention for institutional-grade B2B software companies settling in the 110% to 120% range in 2025. A company with net retention above 110% is expanding faster than it churns, which is the revenue quality profile growth equity investors want to see at the Series B stage.

Continue reading this series:

The Capital Raise Pre-Flight is IRC Partners’ fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership. It is where every engagement begins, whether you are pre-revenue building toward a first institutional round or scaling a company that has raised before. For deals that clear, the full strategic partnership follows. IRC Partners advises operators raising $5M to $250M of institutional capital. If you are taking a raise to market, start here. 

Need guidance on your capital raise?

IRC Partners advises operators raising $5M to $250M of institutional capital. The Capital Raise Pre-Flight runs your deal through critical investor screening gates before any of them see it.
Book Your Pre-Flight Consult
Share this post:
Related Reading

Disclosure

The content published on this website is provided by IRC Partners (InvestorReadyCapital.com) for informational and educational purposes only. Nothing contained herein constitutes financial, investment, legal, or tax advice, nor should any content be construed as a solicitation, recommendation, or offer to buy or sell any security or investment product of any kind.
‍
Nothing on this site constitutes an offer to sell, or a solicitation of an offer to purchase, any security under the Securities Act of 1933, as amended, or any applicable state securities laws. Any offering of securities is made only by means of a formal private placement memorandum or other authorized offering documents delivered to qualified investors.
‍
IRC Partners is a capital advisory firm. IRC Partners is not a registered investment adviser under the Investment Advisers Act of 1940 and does not provide investment advice as defined thereunder.
‍
Certain statements in this article may constitute forward-looking statements, including statements regarding market conditions, capital availability, investor demand, and transaction outcomes. Such statements reflect current assumptions and expectations only. Actual results may differ materially due to market conditions, regulatory developments, company-specific factors, and other variables. IRC Partners makes no representation that any outcome, return, or result described herein will be achieved.
‍
References to prior mandates, transaction volume, network credentials, or capital raised are provided for illustrative purposes only and do not constitute a guarantee or prediction of future results. Past performance is not indicative of future outcomes. Individual results will vary. Network credentials and transaction statistics referenced on this site reflect the aggregate experience of IRC Partners' principals and affiliated advisors and are not a representation of assets managed or transactions closed solely by IRC Partners.
‍
Certain data, statistics, and information presented in this article have been obtained from third-party sources. IRC Partners has not independently verified such information and expressly disclaims responsibility for its accuracy, completeness, or timeliness. Readers should independently verify any third-party data before relying on it.
‍
Readers are strongly encouraged to consult qualified legal, financial, and tax professionals before making any investment, capital raising, or business decision.

Schedule A Meeting

You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.

We onboard a maximum of seven
 new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.